122 related articles for article (PubMed ID: 89555)
21. Properties of purified salivary ribonuclease, and salivary ribonuclease levels in children with cystic fibrosis and in heterozygous carriers.
Bardoń A; Shugar D
Clin Chim Acta; 1980 Feb; 101(1):17-24. PubMed ID: 7357736
[TBL] [Abstract][Full Text] [Related]
22. Cystic fibrosis carrier detection using a linked gene probe.
Farrall M; Scambler P; Klinger KW; Davies K; Worrall C; Williamson R; Wainwright B
J Med Genet; 1986 Aug; 23(4):295-9. PubMed ID: 3018247
[TBL] [Abstract][Full Text] [Related]
23. Distribution of serum amylase isoenzymes in cystic fibrosis homozygotes and heterozygotes.
Takács O; Sohár I; László A; Pénzes P; Gyurkovits K
Acta Paediatr Acad Sci Hung; 1977; 18(1):21-6. PubMed ID: 602748
[TBL] [Abstract][Full Text] [Related]
24. Detection of cystic fibrosis heterozygotes using the zeta potential reduction method.
Litt M; Khan MA
Tex Rep Biol Med; 1976; 34(1):151-4. PubMed ID: 996785
[TBL] [Abstract][Full Text] [Related]
25. Salivary ribonuclease in cystic fibrosis and control subjects.
Bardon A; Ceder O; Ekbohm G; Kollberg H
Acta Paediatr Scand; 1984 Mar; 73(2):263-6. PubMed ID: 6741526
[TBL] [Abstract][Full Text] [Related]
26. Detection of the cystic fibrosis protein by isoelectric focusing of serum and plasma.
Grataroli R; Guy-Crotte O; Galabert C; Figarella C
Pediatr Res; 1984 Feb; 18(2):130-3. PubMed ID: 6701041
[TBL] [Abstract][Full Text] [Related]
27. Loss of the ciliary inhibitory effect of the cystic fibrosis factor following proteolytic digestion and heat denaturation.
Barnett DR; Kurosky A; Bowman BH; Barranco SC
Tex Rep Biol Med; 1973; 31(4):697-701. PubMed ID: 4595587
[No Abstract] [Full Text] [Related]
28. Cystic fibrosis: present status and future prospects in detection of patients and carriers.
Forstner G; Crozier DN; Sturgess JM
Can Med Assoc J; 1975 Sep; 113(6):550-6. PubMed ID: 1156983
[TBL] [Abstract][Full Text] [Related]
29. Rapid nonradioactive detection of the major cystic fibrosis mutation.
Rommens J; Kerem BS; Greer W; Chang P; Tsui LC; Ray P
Am J Hum Genet; 1990 Feb; 46(2):395-6. PubMed ID: 2301405
[No Abstract] [Full Text] [Related]
30. Operational definition of cystic fibrosis. I.
Hösli P; Kollberg H; Vogt E
Monogr Paediatr; 1979; 10():90-5. PubMed ID: 460285
[No Abstract] [Full Text] [Related]
31. Further studies on lymphocyte beta-glucuronidase abnormality in cystic fibrosis. Possible relations to carboxypeptidase B-like activity.
Marchi AG; Marchi MA; Cigui I; Uxa F; Perticarari S; Nordio S
Helv Paediatr Acta; 1978 Dec; 33(6):517-25. PubMed ID: 738902
[TBL] [Abstract][Full Text] [Related]
32. Bovine plasma beta-mannosidase activity and its potential use for beta-mannosidosis carrier detection.
Cavanagh KT; Jones MZ; Abbitt B; Skinner R
J Vet Diagn Invest; 1992 Oct; 4(4):434-40. PubMed ID: 1457547
[TBL] [Abstract][Full Text] [Related]
33. Distinguishing homozygous and heterozygous cystic fibrosis fibroblasts from normal cells by differences in sodium transport.
Breslow JL; McPherson J; Epstein J
N Engl J Med; 1981 Jan; 304(1):1-5. PubMed ID: 7432432
[TBL] [Abstract][Full Text] [Related]
34. Increased monocyte oxidase activity in cystic fibrosis heterozygotes and homozygotes.
Regelmann WE; Skubitz KM; Herron JM
Am J Respir Cell Mol Biol; 1991 Jul; 5(1):27-33. PubMed ID: 1652266
[TBL] [Abstract][Full Text] [Related]
35. Studies on cystic fibrosis using isoelectric focusing. I. An assay for detection of cystic fibrosis homozygotes and heterozygote carriers from serum.
Wilson GB; Fudenberg HH; Jahn TL
Pediatr Res; 1975 Aug; 9(8):635-40. PubMed ID: 239381
[TBL] [Abstract][Full Text] [Related]
36. Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride.
Witko-Sarsat V; Allen RC; Paulais M; Nguyen AT; Bessou G; Lenoir G; Descamps-Latscha B
J Immunol; 1996 Sep; 157(6):2728-35. PubMed ID: 8805680
[TBL] [Abstract][Full Text] [Related]
37. The glycoprotein-degrading potential of peripheral leukocytes in cystic fibrosis.
Isenberg JN; Sahlstrom SJ; Sharp HL
Am Rev Respir Dis; 1976 Apr; 113(4):567-9. PubMed ID: 1267259
[TBL] [Abstract][Full Text] [Related]
38. Growth induction in cystic fibrosis fibroblasts with low dexamethasone concentrations. Experience with application to genotyping.
Daniel A; Stewart L; Lam-Po-Tang PR; Beveridge J; Morton J
Hum Genet; 1981; 57(1):96-8. PubMed ID: 7262876
[TBL] [Abstract][Full Text] [Related]
39. Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis.
Trapnell BC; Chu CS; Paakko PK; Banks TC; Yoshimura K; Ferrans VJ; Chernick MS; Crystal RG
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6565-9. PubMed ID: 1713683
[TBL] [Abstract][Full Text] [Related]
40. Cystic fibrosis protein, a confirmed diagnostic marker for detecting heterozygote carriers: significance in relation to future screening and to a proposed primary defect in alpha 2-macroglobulin.
Wilson GB
Pediatr Res; 1979 Sep; 13(9):1079-81. PubMed ID: 92006
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
